Insider Sell Andrew Dickinson Sells Shares of Gilead Sciences Inc
| CAMOX Fund | USD 28.23 0.18 0.64% |
Slightly above 53% of Cambiar Opportunity's investor base is interested to short. The analysis of overall sentiment of trading Cambiar Opportunity Fund mutual fund suggests that many investors are impartial at this time. Cambiar Opportunity's investing sentiment can be driven by a variety of factors including economic data, Cambiar Opportunity's earnings reports, geopolitical events, and overall market trends.
Cambiar |
On January 15, 2025, Andrew Dickinson, Chief Financial Officer of Kite Pharma, a subsidiary of Gilead Sciences Inc , sold 2,500 shares of the company. Fol
Read at gurufocus.com
 |
Cambiar Opportunity Fundamental Analysis
We analyze Cambiar Opportunity's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Cambiar Opportunity using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Cambiar Opportunity based on its fundamental data. In general, a quantitative approach, as applied to this mutual fund, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Ten Year Return
Ten Year Return Comparative Analysis
Cambiar Opportunity is currently under evaluation in ten year return among similar funds. Ten Year Return shows the total annualized return generated from holding a fund for the last 10 years and represents fund's capital appreciation, including dividends losses and capital gains distributions. This return indicator is considered by many investors to be the ultimate measures of fund performance and can reflect the overall performance of the market or market segment it invests in.
Cambiar Opportunity Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Cambiar Opportunity mutual fund to make a market-neutral strategy. Peer analysis of Cambiar Opportunity could also be used in its relative valuation, which is a method of valuing Cambiar Opportunity by comparing valuation metrics with similar companies.
Peers
Cambiar Opportunity Related Equities
| FHYTX | Federated High | 0.31 | ||||
| TFBIX | Maryland Tax | 0.30 | ||||
| ANAGX | Ab Global | 0.29 | ||||
| TBGAX | Georgia Tax-free | 0.28 | ||||
| PRINX | T Rowe | 0.27 | ||||
| GHVIX | Gmo High | 0.12 | ||||
| PRVBX | Versatile Bond | 0.05 |
Other Information on Investing in Cambiar Mutual Fund
Cambiar Opportunity financial ratios help investors to determine whether Cambiar Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Cambiar with respect to the benefits of owning Cambiar Opportunity security.
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing |